The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Protein Carbamylation Renders High-Density Lipoprotein Dysfunctional
Open accessAbstract
Carbamylation of proteins through reactive cyanate has been demonstrated to predict an increased cardiovascular risk. Cyanate is formed in vivo by breakdown of urea and at sites of inflammation by the phagocyte protein myeloperoxidase. Because myeloperoxidase (MPO) associates with high-density lipoprotein (HDL) in human atherosclerotic intima, we examined in the present study whether cyanate specifically targets HDL. Mass spectrometry analysis revealed that protein carbamylation is a major posttranslational modification of HDL. The carbamyllysine content of lesion-derived HDL was more than 20-fold higher in comparison with 3-chlorotyrosine levels, a specific oxidation product of MPO. Notably, the carbamyllysine content of lesion-derived HDL was five- to eightfold higher when compared with lesion-derived low-density lipoprotein (LDL) or total lesion protein and increased with lesion severity. The carbamyllysine content of HDL, but not of LDL, correlated with levels of 3-chlorotyrosine, suggesting that MPO mediated carbamylation in the vessel wall. Remarkably, one carbamyllysine residue per HDL-associated apolipoprotein A-I was sufficient to induce cholesterol accumulation and lipid-droplet formation in macrophages through a pathway requiring the HDL-receptor scavenger receptor class B, type I. The present results raise the possibility that HDL carbamylation contributes to foam cell formation in atherosclerotic lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myeloperoxidase: friend and foe
Klebanoff, S. J. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1204697 · Cited by 2,282 · cited 1×
“Subsequently, it was found that 3-chlorotyrosine (a specific fingerprint of the MPO/H 2 O 2 /Cl - system) is enriched on lesion-derived HDL, indicating that MPO selectively targets HDL for oxidative modification in atherosclerotic lesions (4, 11, 18, 19, 39).”
Antiinflammatory Properties of HDL
Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146094.59640.13 · Cited by 1,394
Bergt, C., Pennathur, S., Fu, X., Byun, J., O'Brien, K., McDonald, T. O., Singh, P., Anantharamaiah, G. M., Chait, A., Brunzell, J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405292101 · Cited by 454
Chinetti, G., Gbaguidi, F. G., Griglio, S., Mallat, Z., Antonucci, M., Poulain, P., Chapman, J., Fruchart, J.-C., Tedgui, A., Najib-Fruchart, J., et al. (2000) · Circulation · doi:10.1161/01.cir.101.20.2411 · Cited by 428
Thiocyanate and chloride as competing substrates for myeloperoxidase
van DALEN, J. C., WHITEHOUSE, W. M., WINTERBOURN, C. C., & KETTLE, J. A. (1997) · Biochemical Journal · doi:10.1042/bj3270487 · Cited by 406 · cited 1×
“This could be of particular importance, because thiocyanate, even at low physiologic concentrations, is reported to be the preferred substrate for MPO (7, 34).”
Research works printed but not linked: 34
- 10.1681/ASN.2010040365 · DOI
- 10.1373/clinchem.2004.044032 · DOI
- Damm M, , Holzer M, , Radspieler G, , Marsche G, , Kappe CO. Microwave-assisted high-throughput acid hydrolysis in silicon carbide microtiter platforms: a rapid and low volume sample preparation technique for total amino acid analysis in proteins and peptides. J Chromatogr A, 35:363–379. 2010.
- 10.1021/jp058144t · doi:10.1021/jp058144t
- 10.1161/01.ATV.17.11.2685 · DOI
- 10.1016/S0891-5849(97)00084-1 · DOI
- 10.1161/01.RES.85.1.108 · DOI · Paper page
- Kraus LM, , Elberger AJ, , Handorf CR, , Pabst MJ, , Kraus APJr. Urea-derived cyanate forms epsilon-amino-carbamoyl-lysine (homocitrulline) in leukocyte proteins in patients with end-stage renal disease on peritoneal dialysis. J Lab Clin Med, 123:882–891. 1994.
- 10.1172/JCI14011 · DOI · Paper page
- 10.1161/ATVBAHA.109.194548 · DOI · Paper page
- 10.1074/jbc.M112103200 · DOI
- 10.1161/CIRCRESAHA.108.193169 · DOI
- 10.1042/BJ20061406 · DOI
- 10.1093/cvr/cvn051 · DOI
- 10.1074/jbc.M200503200 · DOI
- 10.1096/fsb2fj000532fje · doi:10.1096/fsb2fj000532fje
- 10.1074/jbc.M308428200 · DOI
- 10.1194/jlr.D700041-JLR200 · DOI · Paper page
- 10.1016/S0021-9258(18)34756-2 · DOI · Paper page
- 10.1016/j.tcm.2007.03.005 · doi:10.1016/j.tcm.2007.03.005
- 10.1074/jbc.272.28.17551 · DOI · Paper page
- 10.1194/jlr.R800036-JLR200 · DOI · Paper page
- Oimomi M, , Nishimoto S, , Matsumoto S, , Hatanaka H, , Ishikawa K, , Kawasaki T, , Yoshimura Y, , Baba S. Carbamylated plasma protein in renal failure. Nippon Jinzo Gakkai Shi, 28:269–271. 1986.
- 10.1016/0005-2736(69)90156-4 · doi:10.1016/0005-2736(69)90156-4
- 10.1074/jbc.M110.118182 · DOI
- 10.1161/01.CIR.92.5.1355 · DOI · Paper page
- 10.1152/physrev.00047.2003 · DOI · Paper page
- 10.1186/1471-2261-5-25 · DOI
- 10.1016/S0891-5849(00)00226-4 · DOI · Paper page
- 10.1016/S0002-9440(10)63341-X · DOI · Paper page
- 10.1016/j.yjmcc.2008.03.020 · DOI
- 10.1038/nm1637 · DOI · Paper page
- 10.1016/S0891-5849(00)00204-5 · DOI · Paper page
- 10.1172/JCI200421109 · DOI · Paper page
Cited by
Ito, F., Sono, Y., & Ito, T. (2019) · Antioxidants · doi:10.3390/antiox8030072 · Cited by 535
Zhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023) · MedComm · doi:10.1002/mco2.261 · Cited by 442
Uremia Alters HDL Composition and Function
Holzer, M., Birner-Gruenberger, R., Stojakovic, T., El-Gamal, D., Binder, V., Wadsack, C., Heinemann, A., & Marsche, G. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111144 · Cited by 268
Self-citationAnnema, W., & von Eckardstein, A. (2016) · Translational Research · doi:10.1016/j.trsl.2016.02.008 · Cited by 94
Halogenation Activity of Mammalian Heme Peroxidases
Arnhold, J., & Malle, E. (2022) · Antioxidants · doi:10.3390/antiox11050890 · Cited by 40
Metadata
- Authors
- Holzer, M., Gauster, M., Pfeifer, T., Wadsack, C., Fauler, G., Stiegler, P., Koefeler, H., Beubler, E., Schuligoi, R., Heinemann, A., & Marsche, G.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2011-06-15
- Volume
- 14
- Issue
- 12
- Pages
- 2337-2346
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W2004163374
- Cited by
- 159
- References
- 5
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.